Disposal of atrial natriuretic factor (ANF₉₉-₁₂6) in patients with cirrhosis: Effect of beta-adrenergic blockade

References

• De Bold A J., Borenstein H B., Veress A T., Sonnen-Berg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 1981; 28: 89–94
   PubMed Web of Science ®Google Scholar
• Laragh J H. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Eng J. Med 1985; 313: 1330–40
   PubMed Web of Science ®Google Scholar
• Bonkovsky H L., Hartle D K., Melleu B G., Kutner B, Galambas J J. Plasma concentrations of immuno-reactive atrial natriuretic peptide in hospitalized cirrhotic and non-cirrhotic patients: Evidence for a role of deficient atrial natriuretic peptide in pathogenesis of cirrhotic ascites. Am J Gastroenterol. 1988; 83: 531–5
   PubMed Web of Science ®Google Scholar
• Shenker Y, Sider R S., Ostafin E A., Grekin J. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. I Clin Invest 1985; 76: 1684–7
   PubMed Web of Science ®Google Scholar
• Henriksen J H., Schiitten H J., Bendtsen F, Warberg J. Circulating atrial natriuretic peptide (ANF) and central blood volume (CBV) in cirrhosis. Liver 1986; 6: 363–8
   Google Scholar
• Salerno F, Badalamenti S, Moser P, Lorenzano E, Incerti P, Diugardi N. Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis. Gastroenterology 1990; 98: 1063–70
   PubMed Web of Science ®Google Scholar
• Gerbes A L., Arendt R M., Paumgartner G. Atrial natriuretic factor. Possible implications in liver disease. Hepatology 1987; 5: 123–32
   Google Scholar
• Skorecki K L., Leung W M., Campbell P, Warner L C., Bull S, Logan A C., Blendis L M. Role of atrial natriuretic peptide in the natriuretic response to central volume expansion induced by head-out water immersion in sodium-retaining cirrhotic subject. Am J Med 1988; 85: 375–82
   PubMed Web of Science ®Google Scholar
• Gines P, Jimenez W, Arroyo V, Navasa M, Lopez C, Tito L, Serra A. Atrial natriuretic factor (ANF) in cirrhosis. Plasma levels, cardiac release and splanchnic extraction. Hepatology 1988; 8: 636–42
   PubMed Web of Science ®Google Scholar
• Crozier I G., Nicholls M G., Ikram H, Espiner E A., Yandle T G., Jans S. Atrial natriuretic peptide in humans. Production and clearance by various tissues. Hypertension 1986; 8: 11–15
   PubMed Web of Science ®Google Scholar
• Schiitten H J., Henriksen J H., Warberg J. Organ extraction of atrial natriuretic peptide (ANP) in man. Significance of sampling site. Clin Physiol 1987; 7: 125–32
   PubMedGoogle Scholar
• Hollister A S., Rodeheffer R J., White F J., Pots J R., Imada T, Inagami T. Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog. J Clin Invest 1989; 83: 623–8
   PubMed Web of Science ®Google Scholar
• Gerbes A L., Vollmar A. Processing and clearance of atrial natriuretic factors (ANF). Degradation of Bioactive Substances: Physiology and Pathophysiology, J H. Henriksen. CRC-Press, Boca Raton, Florida 1991; 129–41
   Google Scholar
• The PROVA Study Group. Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: A randomized multicenter trial. Hepatology 1991; 14: 1016–24
   PubMed Web of Science ®Google Scholar
• Bendtsen F, Henriksen J H., Sørensen T IA, Christensen N J. Effect of oral propranolol on circulating catecholamines in cirrhosis: Relationship to severity of liver disease and splanchnic haemody-namics. J Hepatol 1990; 10: 198–204
   PubMed Web of Science ®Google Scholar
• Henriksen J H., Bendtsen F, Gerbes A L. Splanchnic removal of human alpha-atrial natriuretic peptide in humans: Enhancement after food intake. Metabolism 1990; 39: 553–6
   PubMed Web of Science ®Google Scholar
• Bosch J, Mastai R, Kravetz D, Bruix J, Rigau J, Rodes J. Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis. Clinical and hemodynamic correlations in 100 patients. J. Hepatol 1985; 1: 125–39
   PubMed Web of Science ®Google Scholar
• Henriksen J H., Ring-Larsen H, Kanstrup I-L, Christensen N J. 1034–43
   Google Scholar
• Henriksen J H., Winkler K. Hepatic blood flow determination. A comparison of Tc-Diethyl-IDA and indocyanine green as hepatic blood flow indicators in man. J Hepatol 1987; 4: 66–70
   PubMed Web of Science ®Google Scholar
• Bendtsen F, Henriksen J H., Sørensen T IA. Propranolol and haemodynamic response in cirrhosis. J Hepatol 1991; 13: 144–8
   PubMed Web of Science ®Google Scholar
• Arendt R M., Gerbes A L., Ritter D, Stangle E. Molecular weight heterogeneity of plasma-ANF in cardio-vascular disease. Klin Wochenschr 1986; 64(Suppl6)97–102
   PubMedGoogle Scholar
• Gerbes A L., Wernze H, Arendt R M., Riedel A, Sauerbruch T, Paumgartner G. Atrial natriurecic factor (ANF) and renin-aldosterone in volume regulation of patients with cirrhosis. Hepatology 1989; 9: 417–22
   PubMed Web of Science ®Google Scholar
• Degradation of Bioactive Substances: Physiology and Pathophysiology, J H. Henriksen. CRC Press, Inc., Boca Raton, Florida 1991
   Google Scholar
• Tranberg K-G. Hepatic uptake of insulin in man. Am J Physiol 1979; 237: E509–18
   PubMed Web of Science ®Google Scholar
• Stephenson S L., Kenny A J. The hydrolysis of alpha-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopep-tidase-24.11. Biochem J 1987; 243: 183–7
   PubMed Web of Science ®Google Scholar
• Sonnenberg J L., Skakane Y, Jeng A Y., Koehn J A., Ansell J A., Wennogle L P., Ghai R D. Identifications of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney. Peptides 1988; 9: 173–80
   PubMed Web of Science ®Google Scholar
• Chinkers M, Garbers D L., Chang M-S, Lowe D G., Chin H M., Goeddel D V., Schulz S. A membrane form of guanylate cyclase in an atrial natriuretic peptide receptor. Nature 1989; 338: 78–83
   PubMed Web of Science ®Google Scholar
• Almeida F A., Suzuki M, Scarborough R M., Lewicki J A., Maack T. Clearance function of type C receptors of atrial natriuretic factor in rats. Am J Physiol 1989; 256: R469–75
   PubMed Web of Science ®Google Scholar
• Kollenda M C., Vollmar A M., McEnroe G A., Gerbs A L. Dehydration increases the density of C-recep-tors for ANF on rat glomerular membranes. Am J Physiol 1990; 258: R1084–88
   Google Scholar
• Schulz S, Chinkers M, Garbers D L. The guanylate cyclase/receptor family of proteins. FASEB J 1989; 3: 2026
   PubMed Web of Science ®Google Scholar
• Fuller F, Porter J G., Arfsten A E., Miller J, Schilling J W., Scarborough R M., Lewicki J A. Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones. J Biol Chem 1988; 263: 9395–9
   PubMed Web of Science ®Google Scholar
• Kenny A K., Maroux S. Topology of microvillar membrane hydrolases of kidney and intestine. Physiol Rev 1982; 62: 91–118
   PubMed Web of Science ®Google Scholar
• Gee N S., Bowes M A., Buck P, Kenny A J. An immuno-radiometric assay for endopeptidase-24.11 shows it to be a widely distributed enzyme in pig tissues. Biochem J 1985; 228: 119–25
   PubMed Web of Science ®Google Scholar
• Mantyh C R., Kruger L, Brecha N C., Mantyh P W. Localization of specific binding sites for atrial natriuretic factor in peripheral tissues of the guinea pig, rat and human. Hypertension 1986; 8: 712–21
   PubMed Web of Science ®Google Scholar
• Bianchi C, Gutkowska J, Thibault G, Garcia R, Genest J, Cantin M. Radioautographic localization of I-atrial natriuretic factor (ANF) in rat tissues. Histochemistry 1985; 82: 441–52
   PubMedGoogle Scholar
• Stewart R E., Swithers S E., Plunkett L M., McCarty R. ANF receptors: Distribution and regulation in central and peripheral tissues. Neurosci Biobehav Rev 1988; 12: 151–68
   PubMed Web of Science ®Google Scholar
• Thamsborg G, Sykulski R, Larsen J, Storm T, Keller N. Effect of β1-adrenoceptor blockade on plasma levels of atrial natriuretic peptide during exercise in normal man. Clin Physiol 1987; 7: 313–8
   PubMedGoogle Scholar
• Nguyen P V., Smith D L., Leenen F F. Acute volume loading, atrial natriuretic peptide release and cardiac function in healthy men. Effect of /3-blockade. Life Sci 1988; 43: 821–30
   PubMed Web of Science ®Google Scholar
• Sonnenberg H, Veress A T. Cellular mechanism of release of atrial,natriuretic factor. Biochem Bio-phys Res Commun 1984; 124: 443–9
   PubMed Web of Science ®Google Scholar
• Garcia R, Lahance D, Thibault G, Cantin M, Gutkowska J. Mechanisms of release of atrial natriuretic factor. II. Effect of chronic administration of α- and β-adrenergic and cholinergic agonists on plasma and atrial ANF in the rat. Biochem Bio-phys Res Commun 1986; 136: 510–20
   PubMed Web of Science ®Google Scholar
• Keller N, Larsen J, Sykulski R, Storm T, Thamsborg G. Atrial natriuretic factor during exercise in patients with congestive heart failure. Acta Endocrinol (Copenh) 1988; 118: 168–72
   PubMedGoogle Scholar
• Vollmer-Larsen B, Vollmer-Larsen A, Larsen O G., Breum L, Larsen J, Keller N. Atrial natriuretic factor during exercise in male endurance athletes: effect of training. Clin Physiol 1989; 9: 449–56
   PubMedGoogle Scholar